Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 106 to 120 of 369 results for depression

  1. Stroke and transient ischaemic attack in over 16s. Patient decision aid on decompressive hemicraniectomy surgery in people under 60

    seizures (fits), be incontinent, and have problems with mood, particularly depression. Decompressive hemicraniectomy may also cause...

  2. Stroke and transient ischaemic attack in over 16s. Patient decision aid on decompressive hemicraniectomy surgery in people over 60

    seizures (fits), be incontinent, and have problems with mood, particularly depression. Decompressive hemicraniectomy may also cause...

  3. Endoscopic radiofrequency therapy of the anal sphincter for faecal incontinence (IPG393)

    Evidence-based recommendations on endoscopic radiofrequency therapy of the anal sphincter for faecal incontinence. This involves applying radiofrequency energy to the anal wall, with the aim of inducing muscle changes to improve muscle tone and help control bowel movement.

    Interventional procedures guidance
    Published
    25 May 2011
    View recommendations

    Sections for IPG393

  4. Alcohol-use disorders: prevention (PH24)

    This guideline covers alcohol problems among people over 10. It aims to prevent and identify such problems as early as possible using a mix of policy and practice.

    Public health guideline
    Published
    2 June 2010
    View recommendations

    Sections for PH24

  5. Idiopathic pulmonary fibrosis in adults: diagnosis and management (CG163)

    This guideline covers diagnosing and managing idiopathic pulmonary fibrosis in people aged 18 and over. It aims to improve the quality of life for people with idiopathic pulmonary fibrosis by helping healthcare professionals to diagnose the condition and provide effective symptom management.

    Clinical guideline
    Last updated
    23 May 2017
    View recommendations

    Sections for CG163

  6. Epilepsies in children, young people and adults (NG217)

    This guideline covers diagnosing and managing epilepsy in children, young people and adults in primary and secondary care, and referral to tertiary services. It aims to improve diagnosis and treatment for different seizure types and epilepsy syndromes, and reduce the risks for people with epilepsy.

    NICE guideline
    Last updated
    30 January 2025

    Sections for NG217

  7. Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C (TA200)

    Evidence-based recommendations on peginterferon alfa (Pegasys; ViraferonPeg) and ribavirin for treating chronic hepatitis C in adults.

    Technology appraisal guidance
    Published
    22 September 2010
    View recommendations

    Sections for TA200

  8. Ovarian cancer: recognition and initial management (CG122)

    This guideline covers detecting, diagnosing and treating women (aged 18 and older) who have, or are suspected of having, epithelial ovarian cancer, fallopian tube cancer, primary peritoneal cancer or borderline ovarian cancer. It aims to enable earlier detection of ovarian cancer and improve initial treatment.

    Clinical guideline
    Last updated
    2 October 2023
    View recommendations

    Sections for CG122

  9. Delirium assessment tools:What is the diagnostic accuracy, and ease of implementation, of different delirium assessment tools: for people with pre-existing cognitive impairment, for example dementia, learning disability or severe depression for people who do not speak English as a first language in different settings, for example emergency departments, residential care homes or virtual consultations when delivered by different types of health and social care practitioners, for example healthcare assistants or allied health professionals such as paramedics?

    cognitive impairment, for example dementia, learning disability or severe depression for people who do not speak English as a first...

    Research recommendation
    Published
    3 February 2023

  10. How effective and cost effective are interventions to increase vitamin D access, uptake, adherence or status among identified at-risk groups? Does effectiveness vary by age, gender, ethnicity, socioeconomic or other specific population characteristics (such as depression or a disability)? The following could be considered: - availability and uptake of supplements (including the impact of the cost of supplements) - type of supplements provided and how that impacts on adherence - knowledge and attitudes (of both the public and health and social care practitioners).

    ethnicity, socioeconomic or other specific population characteristics (such as depression or a disability)? The following could be...

    Research recommendation
    Published
    9 June 2015

  11. Further research is recommended to help address remaining clinical and cost-effectiveness uncertainties for esketamine, summarised in section 3.36 .

    recommended in the wider clinical area of depression on: • how clinical data from regulatory trials in depression could...

    Research recommendation
    Published
    6 January 2023

  12. MRI-guided focused ultrasound thalamotomy for treating moderate to severe tremor in Parkinson's (IPG796)

    Evidence-based recommendations on MRI-guided focused ultrasound thalamotomy for treating moderate to severe tremor in Parkinson’s. This involves using ultrasound to destroy tissue in the thalamus.

    Interventional procedures guidance
    Published
    18 December 2024
    View recommendations

    Sections for IPG796

  13. MRI-guided focused ultrasound subthalamotomy for treating Parkinson's (IPG797)

    Evidence-based recommendations on MRI-guided focused ultrasound subthalamotomy for treating Parkinson’s. This involves using ultrasound to destroy tissue in an area of the brain linked to Parkinson’s symptoms.

    Interventional procedures guidance
    Published
    18 December 2024
    View recommendations

    Sections for IPG797

  14. End of life care for infants, children and young people with life-limiting conditions: planning and management (NG61)

    This guideline covers the planning and management of end of life and palliative care for infants, children and young people (aged 0 to 17 years) with life-limiting conditions. It aims to involve children, young people and their families in decisions about their care, and improve the support that is available to them throughout their lives.

    NICE guideline
    Last updated
    25 July 2019
    View recommendations

    Sections for NG61

  15. Social, emotional and mental wellbeing in primary and secondary education (NG223)

    This guideline covers ways to support social, emotional and mental wellbeing in children and young people in primary and secondary education (key stages 1 to 5), and people 25 years and under with special educational needs or disability in further education colleges. It aims to promote good social, emotional and psychological health to protect children and young people against behavioural and health problems.

    NICE guideline
    Published
    6 July 2022
    View recommendations

    Sections for NG223